Computational prediction of microRNA networks incorporating environmental toxicity and disease etiology

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Li, Jie ^a   Wu, Zengrui ^a   Cheng, Feixiong ^a   Li, Weihua ^a   Liu, Guixia ^a   Tang, Yun ^a,b  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Shanghai Tobacco Group Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PASSIVE SMOKING;

ADVERSE EFFECTS; AREA UNDER THE CURVE; BREAST TUMOR; COMPUTER SIMULATION; ENVIRONMENTAL EXPOSURE; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LUNG NEOPLASMS; METABOLISM; PASSIVE SMOKING; PHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; RNA INTERFERENCE;

AREA UNDER CURVE; BREAST NEOPLASMS; COMPUTER SIMULATION; ENVIRONMENTAL EXPOSURE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENE-ENVIRONMENT INTERACTION; HUMANS; LUNG NEOPLASMS; MICRORNAS; RISK FACTORS; RNA INTERFERENCE; ROC CURVE; TOBACCO SMOKE POLLUTION;

EID: 84903977748     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05576     Document Type: Article

References (54)

1. Lee, R. C., Feinbaum, R. L. & Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854 (1993). (Pubitemid 24014542)
2. Lee, R. C. & Ambros, V. An extensive class of small RNAs in Caenorhabditis elegans. Science 294, 862-864 (2001). (Pubitemid 33032105)
3. Ambros, V. The functions of animal microRNAs. Nature 431, 350-355 (2004). (Pubitemid 39265675)
4. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
5. Friedman, R. C., Farh, K. K.-H., Burge, C. B. & Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19, 92-105 (2009).
6. Niemoeller, O. M. et al.MicroRNA expression profiles in human cancer cells after ionizing radiation. Radiat Oncol 6, 29 (2011).
7. Jardim, M. J.MicroRNAs: implications for air pollution research. Mutat Res-Fund Mol M 717, 38-45 (2011).
8. Graff, J. W. et al. Cigarette smoking decreases global microRNA expression in human alveolar macrophages. PLoS One 7, e44066 (2012).
9. Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nat Rev Cancer 6, 857-866 (2006). (Pubitemid 44629897)
10. Lukiw, W. J. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 18, 297-300 (2007).
11. Van Rooij, E.&Olson, E.N.MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117, 2369-2376 (2007). (Pubitemid 47494334)
12. Baccarelli, A. & Bollati, V. Epigenetics and environmental chemicals. Curr Opin Pediatr 21, 243 (2009).
13. Hudder, A.&Novak, R. F. miRNAs: effectors of environmental influences on gene expression and disease. Toxicol Sci 103, 228-240 (2008). (Pubitemid 351659596)
14. Wang, J. & Cui, Q. H. Specific roles of microRNAs in their interactions with environmental factors. J Nucleic Acids 2012, 978384 (2012).
15. Chen, T. The role of microRNA in chemical carcinogenesis. J Environ Sci Heal C 28, 89-124 (2010).
16. Xi, S. C. et al. Cigarette smoke induces C/EBP-b-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells. PLoS One 5, e13764 (2010).
17. Tilghman, S. L. et al. Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. PLoS One 7, e32754 (2012).
18. Cheng, F. X. et al. admetSAR: a comprehensive source and free tool for assessment of chemical admet properties. J Chem Inf Model 52, 3099-3105 (2012).
19. Cheng, F. X. et al. Prediction of human genes and diseases targeted by xenobiotics using predictive toxicogenomic-derived models (PTDMs). Mol BioSyst 9, 1316-1325 (2013).
20. Audouze, K. et al. Deciphering diseases and biological targets for environmental chemicals using toxicogenomics networks. PLoS Comput Biol 6, e1000788 (2010).
21. Audouze, K. & Grandjean, P. Application of computational systems biology to explore environmental toxicity hazards. Environ Health Persp 119, 1754 (2011).
22. Cheng, F. X., Li, W. H., Liu, G. X. & Tang, Y. In silico ADMET prediction: recent advances, current challenges and future trends. Curr Top Med Chem 13, 1273-1289 (2013).
23. Qiu, C. X., Chen, G. & Cui, Q. H. Towards the understanding of microRNA and environmental factor interactions and their relationships to human diseases. Sci Rep 2, doi:10.1038/srep00318 (2012).
24. Jiang, W. et al. Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses. Sci Rep 2, doi:10.1038/srep00282 (2012).
25. Chen, X., Liu, M. X., Cui, Q. H. & Yan, G. Y. Prediction of disease-related interactions between microRNAs and environmental factors based on a semisupervised classifier. PLoS One 7, e43425 (2012).
26. Cheng, F. X. et al. Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput Biol 8, e1002503 (2012).
27. Bader, G. D. & Hogue, C. W. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 4, 2 (2003).
28. Beveridge, N. J., Gardiner, E., Carroll, A. P., Tooney, P. A. & Cairns, M. J. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatr 15, 1176-1189 (2009).
29. Barabási, A. L.&Albert, R. Emergence of scaling in random networks. Science 286, 509-512 (1999).
30. Boyle, P. & Levin, B. World Cancer Report 2008. (IARC Press, InteRNAtional Agency for Research on Cancer, 2008).
31. Dvinge, H. et al. The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 497, 378-382 (2013).
32. Zaman, N. et al. Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets. Cell Rep 5, 216-223 (2013).
33. Heiser, L. M. et al. Subtype and pathway specific responses to anticancer compounds in breast cancer. Proc Natl Acad Sci USA 109, 2724-2729 (2012).
34. WHO. The facts about smoking and health. (2006).
35. Banerjee, A. & Luettich, K. MicroRNAs as potential biomarkers of smokingrelated diseases. Biomark Med 6, 671-684 (2012).
36. Schembri, F. et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci USA 106, 2319-2324 (2009).
37. Maccani, M. A. et al. Maternal cigarette smoking during pregnancy is associated with downregulation ofmiR-16, miR-21, and miR-146a in the placenta. Epigenetics 5, 583-589 (2010).
38. Ng, T. K. et al. Nicotine alters microRNA expression and hinders human adult stem cell regenerative potential. Stem Cells Dev 22, 781-790 (2012).
39. Chen, X. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18, 997-1006 (2008).
40. Yang, Q. Q., Qiu, C. X., Yang, J., Wu, Q. & Cui, Q. H. miREnvironment database: providing a bridge for microRNAs, environmental factors and phenotypes. Bioinformatics 27, 3329-3330 (2011).
41. Lu, M. et al. An analysis of human microRNA and disease associations. PLoS One 3, e3420 (2008).
42. Watts, D. J. & Strogatz, S. H. Collective dynamics of 'small-world' networks. Nature 393, 440-442 (1998). (Pubitemid 28292183)
43. Cheng, F. X., Zhou, Y. D., Li, W. H., Liu, G. X. & Tang, Y. Prediction of chemicalprotein interactions network with weighted network-based inference method. PLoS One 7, e41064 (2012).
44. Wickramasinghe, N. S. et al. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res 37, 2584-2595 (2009).
45. Selcuklu, S. D., Donoghue, M. T., Kerin, M. J. & Spillane, C. Regulatory interplay between miR-21, JAG1 and 17beta-estradiol (E2) in breast cancer cells. Biochem Bioph Res Co 423, 234-239 (2012).
46. Bhat-Nakshatri, P. et al. Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res 37, 4850-4861 (2009).
47. Wang, D., Wang, J., Lu, M., Song, F. & Cui, Q. H. Inferring the humanmicroRNA functional similarity and functional network based on microRNA-associated diseases. Bioinformatics 26, 1644-1650 (2010).
48. Lusher, S. J. et al. Data-driven medicinal chemistry in the era of big data. Drug Discov Today 19, doi: 10.1016/j.drudis.2013.12.004 (2014).
49. Witkos, T. M., Koscianska, E. & Krzyzosiak, W. J. Practical aspects of microRNA target prediction. Curr Mol Med 11, 93 (2011).
50. Lipscomb, C. E. Medical subject headings (MeSH). Bull Med Libr Assoc 88, 265-266 (2000). (Pubitemid 30482677)
51. Griffiths-Jones, S. The micro RNA registry. Nucleic Acids Res 32, D109-D111 (2004).
52. Willett, P. Similarity-based virtual screening using 2D fingerprints. Drug Discov Today 11, 1046-1053 (2006). (Pubitemid 44792477)
53. O'Boyle, N. M. et al. Open Babel: An open chemical toolbox. J Cheminformatics 3, 1-14 (2011).
54. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498-2504 (2003). (Pubitemid 37428274)